The text discusses two clinical trials related to colon cancer. ASPIK is a randomized study comparing aspirin to a placebo in colon cancer patients with PI3K mutation of stage III or high-risk stage II. PRODIGE 70 - CIRCULATE focuses on adjuvant treatment decisions for stage II colon cancers based on analysis of circulating tumor DNA.